Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / S•••••••

Novvia Group Acquires a Majority Interest in Acepac S•••••••

Exit to a strategic buyerclosedannounced Nov 29, 2021closed Nov 29, 2021Fact
What happened
Target
S•••••••
Platform
not an add-on on record
Control
unknown
Share acquired
unknown
Industry
unknown
Target location
unknown
Seller kind
Sponsor
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
4 named
Buy side
  • I•••••Strategic acquirerconfirmed
    “I•••••, a Novvia Group company backed by K•••• & Company, has acquired a majority interest in the S••••••• operations of Acepac International, to support its Life Sciences Division.”
Sell side
  • K•••• • C••••••• L•••Sellerconfirmed
    “I•••••, a Novvia Group company backed by K•••• & Company, has acquired a majority interest in the S••••••• operations of Acepac International, to support its Life Sciences Division. | published on K•••• & Company's own news page novviagroup.com”
Side not stated
  • F•••• O•••••Managementconfirmed
    “We are excited about the enhanced product and service offerings this acquisition brings to our existing clients, as well as the tremendous growth opportunities this alliance provides I••••• in the region,” said F•••• O•••••, President of I•••••.”
  • S•••••••Targetconfirmed
    “I•••••, a Novvia Group company backed by K•••• & Company, has acquired a majority interest in the S••••••• operations of Acepac International, to support its Life Sciences Division.”
Evidence
“I•••••, a Novvia Group company backed by K•••• & Company, has acquired a majority interest in the S••••••• operations of Acepac International, to support its Life Sciences Division.”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 13, 2026